1 April 1993
17 June 1988
COMMERCIAL ITEM DESCRIPTION
DEXTROSE INJECTION, USP, 5% PARTIAL-FILL
BAGS WITH VIAL ADDITIVE PORT
The General Services Administration has authorized the use of this Commercial Item Description.
Shall be Dextrose Injection, USP, 5%.
Shall be in accordance with the requirements of the USP.
Shall contain 5% Dextrose within the applicable assay limits for the injection.
The solution shall be supplied in an oversized single dose, sterile, transparent, flexible plastic bag having one permanently attached outlet port for administration and one permanently attached inlet port for interlocking a complementary glass small volume parenteral drug vial.
The outlet port shall be force-fitted with a sterility protector with a stab for ease of removal and shall accept and retain the piercing device of the stocklisted administration sets. The outlet port shall be of such design as to hold and make a leak-proof fit with the IV administration set. The inlet port shall have a hermetically sealed sterility protector with ring for ease for use. The inlet port shall be of such design as to facilitate addition of active drugs to the diluents container, and shall accept and make a proper tamper-resistant leak-proof fit, with the complementary glass small volume parenteral drug vials. The combined unit shall be of such design as to prevent the mixing of the two components until just prior to administration.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business